Mainz Biomed NV (FRA:4TO) Interest Expense : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Mainz Biomed NV's interest expense for the three months ended in Dec. 2024 was € 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Mainz Biomed NV's Operating Income for the three months ended in Dec. 2024 was € 0.00 Mil. Mainz Biomed NV's Interest Expense for the three months ended in Dec. 2024 was € 0.00 Mil. GuruFocus does not calculate Mainz Biomed NV's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mainz Biomed NV Interest Expense Historical Data

The historical data trend for Mainz Biomed NV's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Interest Expense Chart

Mainz Biomed NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.22

-0.30

-0.27

-0.51

-1.03

Mainz Biomed NV Quarterly Data
	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial									-	-	-	-	-

Mainz Biomed NV Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Mainz Biomed NV (FRA:4TO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mainz Biomed NV's Interest Expense for the three months ended in Dec. 2024 was €0.00 Mil. Its Operating Income for the three months ended in Dec. 2024 was €0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was €0.83 Mil.

Mainz Biomed NV's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

GuruFocus does not calculate Mainz Biomed NV's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Mainz Biomed NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (FRA:4TO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MYNZ:USA

Address

Robert Koch Strasse 50, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Mainz Biomed NV Headlines

No Headlines